Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ... The Lancet 392 (10150), 821-834, 2018 | 579 | 2018 |
Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis N Kwak, MP Dalcolmo, CL Daley, G Eather, R Gayoso, N Hasegawa, ... European Respiratory Journal 54 (1), 2019 | 205 | 2019 |
Treatment Outcomes of Mycobacterium avium Complex Lung Disease: A Systematic Review and Meta-analysis N Kwak, J Park, E Kim, CH Lee, SK Han, JJ Yim Clinical Infectious Diseases 65 (7), 1077-1084, 2017 | 177 | 2017 |
Lung cancer risk among patients with combined pulmonary fibrosis and emphysema N Kwak, CM Park, J Lee, YS Park, SM Lee, JJ Yim, CG Yoo, YW Kim, ... Respiratory medicine 108 (3), 524-530, 2014 | 124 | 2014 |
Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice N Kwak, SM Choi, J Lee, YS Park, CH Lee, SM Lee, CG Yoo, YW Kim, ... PloS one 8 (10), e77456, 2013 | 98 | 2013 |
Effect of COVID-19 on tuberculosis notification, South Korea N Kwak, SS Hwang, JJ Yim Emerging infectious diseases 26 (10), 2506, 2020 | 91 | 2020 |
BACES score for predicting mortality in nontuberculous mycobacterial pulmonary disease HJ Kim, N Kwak, H Hong, N Kang, Y Im, BW Jhun, JJ Yim American Journal of Respiratory and Critical Care Medicine 203 (2), 230-236, 2021 | 71 | 2021 |
Changes in treatment outcomes of multidrug-resistant tuberculosis N Kwak, HR Kim, CG Yoo, YW Kim, SK Han, JJ Yim The International Journal of Tuberculosis and Lung Disease 19 (5), 525-530, 2015 | 53 | 2015 |
Minimal inhibitory concentration of clofazimine among clinical isolates of nontuberculous mycobacteria and its impact on treatment outcome N Kwak, J Whang, JS Yang, TS Kim, SA Kim, JJ Yim Chest 159 (2), 517-523, 2021 | 46 | 2021 |
Accuracy of the Xpert® MTB/RIF assay for the diagnosis of extra-pulmonary tuberculosis in South Korea YW Kim, N Kwak, MW Seong, EC Kim, CG Yoo, SK Han, JJ Yim The International Journal of Tuberculosis and Lung Disease 19 (1), 81-86, 2015 | 46 | 2015 |
Non-tuberculous mycobacterial lung disease: diagnosis based on computed tomography of the chest N Kwak, CH Lee, HJ Lee, YA Kang, JH Lee, SK Han, JJ Yim European radiology 26, 4449-4456, 2016 | 45 | 2016 |
Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease HJ Kim, JS Lee, N Kwak, J Cho, CH Lee, SK Han, JJ Yim BMC Pulmonary Medicine 19, 1-10, 2019 | 42 | 2019 |
Impact of body mass index on development of nontuberculous mycobacterial pulmonary disease JH Song, BS Kim, N Kwak, K Han, JJ Yim European Respiratory Journal 57 (2), 2021 | 41 | 2021 |
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR … J Mok, M Lee, DK Kim, JS Kim, BW Jhun, KW Jo, D Jeon, T Lee, JY Lee, ... The Lancet 400 (10362), 1522-1530, 2022 | 39 | 2022 |
Improved oxygenation after prone positioning may be a predictor of survival in patients with acute respiratory distress syndrome HY Lee, J Cho, N Kwak, SM Choi, J Lee, YS Park, CH Lee, CG Yoo, ... Critical Care Medicine 48 (12), 1729-1736, 2020 | 39 | 2020 |
Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial JK Lee, JY Lee, DK Kim, HI Yoon, I Jeong, EY Heo, YS Park, YS Jo, ... The Lancet Infectious Diseases 19 (1), 46-55, 2019 | 37 | 2019 |
Longitudinal changes in health-related quality of life according to clinical course among patients with non-tuberculous mycobacterial pulmonary disease: a prospective cohort study N Kwak, SA Kim, SM Choi, J Lee, CH Lee, JJ Yim BMC pulmonary medicine 20, 1-7, 2020 | 33 | 2020 |
Deep learning to determine the activity of pulmonary tuberculosis on chest radiographs S Lee, JJ Yim, N Kwak, YJ Lee, JK Lee, JY Lee, JS Kim, YA Kang, D Jeon, ... Radiology 301 (2), 435-442, 2021 | 32 | 2021 |
New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changes N Kwak, JH Lee, HJ Kim, SA Kim, JJ Yim BMC Pulmonary Medicine 20, 1-7, 2020 | 32 | 2020 |
Final treatment outcomes of delamanid-containing regimens in patients with MDR-/XDR-TB in South Korea J Mok, H Kang, WJ Koh, BW Jhun, JJ Yim, N Kwak, T Lee, B Kang, D Jeon European Respiratory Journal 54 (5), 2019 | 32 | 2019 |